000 01487 a2200433 4500
005 20250518015118.0
264 0 _c20201005
008 202010s 0 0 eng d
022 _a1532-1983
024 7 _a10.1016/j.clnu.2018.11.029
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSun, Chiao-Yin
245 0 0 _aClinical association between the metabolite of healthy gut microbiota, 3-indolepropionic acid and chronic kidney disease.
_h[electronic resource]
260 _bClinical nutrition (Edinburgh, Scotland)
_c12 2019
300 _a2945-2948 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aCase-Control Studies
650 0 4 _aDisease Progression
650 0 4 _aFemale
650 0 4 _aGastrointestinal Microbiome
_xphysiology
650 0 4 _aHumans
650 0 4 _aIndoles
_xblood
650 0 4 _aKidney
_xmicrobiology
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPropionates
_xblood
650 0 4 _aProspective Studies
650 0 4 _aRenal Insufficiency, Chronic
_xblood
700 1 _aLin, Cheng-Jui
700 1 _aPan, Heng-Chih
700 1 _aLee, Chin-Chan
700 1 _aLu, Shang-Chieh
700 1 _aHsieh, Yu-Ting
700 1 _aHuang, Shih-Yi
700 1 _aHuang, Hui-Yu
773 0 _tClinical nutrition (Edinburgh, Scotland)
_gvol. 38
_gno. 6
_gp. 2945-2948
856 4 0 _uhttps://doi.org/10.1016/j.clnu.2018.11.029
_zAvailable from publisher's website
999 _c29224429
_d29224429